377 Millennium - Eighteenth Edition SCIENCES, PHARMACEUTICALS AND BIOTECHNOLOGY vendor partners. In addition, he led a years-long project to create an industry-leading tool that tracks revenue back to individual drug expenses, thus revolutionizing reporting methodology and strategic decision-making. Alongside his other duties, Dr. Wood serves as a pharmacist preceptor and clinical assistant professor at the same academic institution where he earned a PharmD in 2011. As a medical professional, he maintains a patient-first mentality and attributes his success to building strong, collaborative networks and thinking outside the box. Reflecting on his experiences, he believes his positive relationships with patients and colleagues have enabled him to offer and receive valuable feedback and care. In recognition of his exemplary work, Dr. Wood received the inaugural Culture 99 Award from a local hospital where he served as a pharmacist for many years. Dr. Wood is a board-certified biologics and biosimilars specialist, with particular expertise in the 505(b)(2) drug approval pathway. He has dedicated himself to raising awareness of this pathway and its associated implications within his organization and nationwide. He has given multiple presentations, participated in podcasts, published articles, and served on expert panels. Additionally, he is leading multiple advocacy efforts seeking public policy revisions in partnership with federal relations and government affairs teams. Looking ahead, Dr. Wood plans to focus on personal and professional growth. He is dedicated to exploring new opportunities for improvement and optimization, particularly in the wake of COVID-19, which made financial recovery and cost-saving measures top-priority items in the health care industry. Dr. Wood views himself as a lifelong learner, eager and determined to push himself to evolve and continually improve. Dr. Tyler Wood is a distinguished executive at a large health care system consisting of over 50 hospitals across seven states. In his role as system director for pharmacy oncology and biosimilars, he has demonstrated exceptional expertise in drug formulary and utilization management and drug strategy. He has also developed innovative metrics to track financial value for creative contract structures and to establish mutually beneficial partnerships with drug manufacturers and TYLER WOOD, PHARMD SYSTEM DIRECTOR FOR PHARMACY ONCOLOGY AND BIOSIMILARS Conroe, TX
RkJQdWJsaXNoZXIy MjExMDk4NQ==